SLDB compared with OLMA: revenue, margins and what each company keeps, and the suppliers and customers both name

SLDBSolid Biosciences Inc.

Mkt capRevenueRevenue

OLMAOlema Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

SLDBSolid Biosciences Inc.

OLMAOlema Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

SLDB

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q1 FY26±75.6%▲+18.81%×0.25

Q3 FY25±38.3%▼−15.29%×0.40

Feb 18 '25±29.3%▲+31.51%×1.08

Jan 8 '24±15.0%▲+7.59%×0.51

OLMA

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±30.4%▼−12.65%×0.42

May 12 '26±32.7%▼−5.99%×0.18

= impliedSLDB realized, solidOLMA realized, hatchedOne scale, both sides: full bar = 76%× = |realized| ÷ impliedspan: SLDB 791d · OLMA 210dSource: market data

Q1 FY26

±31.6%

▲+12.85%

×0.41

Jan 13 '26±6.4%▼−3.13%×0.48

SLDBSolid Biosciences Inc.

6.20▼−2.97%· post 6.20

Mkt cap$664.8M

OLMAOlema Pharmaceuticals, Inc.

7.01▼−4.43%· post 7.01

ClosedOct 30 '26

Mkt cap$612.5M

Compare

ClosedOct 30 '26

SLDBSolid Biosciences Inc.

OLMAOlema Pharmaceuticals, Inc.

6.20▼−2.97%post 6.20

Price

7.01▼−4.43%post 7.01

$664.8M

Mkt cap

$612.5M

SLDB6.20▼−2.97%vsOLMA7.01▼−4.43%ClosedOct 30 '26